RTW Investments, LP 13D and 13G filings for Stoke Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-02-14 09:00 am Purchase | 2024-12-31 | 13G | Stoke Therapeutics, Inc. STOK | RTW Investments, LP | 5,310,033 9.990% | 1,178,988 (+28.54%) | Filing |
| 2024-02-14 07:44 am Purchase | 2023-12-31 | 13G | Stoke Therapeutics, Inc. STOK | RTW Investments, LP | 4,131,045 9.300% | 260,064 (+6.72%) | Filing |
| 2023-02-14 10:08 am Purchase | 2022-12-31 | 13G | Stoke Therapeutics, Inc. STOK | RTW Investments, LP | 3,870,981 9.800% | 226,733 (+6.22%) | Filing |
| 2022-02-14 08:07 am Purchase | 2021-12-31 | 13G | Stoke Therapeutics, Inc. STOK | RTW Investments, LP | 3,644,248 9.900% | 100,000 (+2.82%) | Filing |
| 2021-02-12 09:40 am Unchanged | 2020-12-31 | 13G | Stoke Therapeutics, Inc. STOK | RTW Investments, LP | 3,544,248 9.890% | 0 (Unchanged) | Filing |